Cigna Stock Falls 11% After Missing Quarterly Profit Estimates on Higher Medical Costs

Reuters
01-30

(Reuters) - Cigna forecast annual profit below Wall Street expectations on Thursday and missed estimates for the fourth quarter, hurt by higher medical costs for a type of employer-sponsored healthcare plan.

Shares of the company fell 11% before the bell.

The plan, called "stop-loss insurance", entails the insurer covering for employers' self-funded plans when their costs surpass a certain threshold due to catastrophic or unexpected medical claims.

The company forecast annual profit per share of at least $29.50, below analysts estimates of $31.50 per share, according to data compiled by LSEG.

Cigna manages employer-sponsored healthcare plans, and unlike its peers, has a smaller presence in the Medicare Advantage market, where insurers have been grappling with increased medical costs driven by demand for healthcare services among older adults.

The health insurer is in the process of selling its Medicare Advantage business to Health Care Service Corp. The divestiture, announced last year, is expected to close in the first quarter of 2025.

For the quarter, its medical care ratio - the percentage of premiums spent on medical care - came in at 87.9%, up from 82.2% a year ago. Analysts expected a ratio of 84.84% for the reported quarter.

"While higher medical costs in our stop-loss product impacted fourth-quarter earnings, we are taking corrective actions to address these near-term pressures," said CEO David Cordani.

On an adjusted basis, Cigna posted fourth-quarter profit of $6.64 per share, compared with estimates of $7.82.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10